MedPath

Comparative study to find the effective dose of sugammadex to reverse the eefectbof muscle relaxants in patients undergoing General Surgery receiving muscle relaxants in general anesthesia

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/06/068590
Lead Sponsor
Vijayanagar Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients included under ASA grade 1 and 2

Exclusion Criteria

1. Renal dysfunction

2. Allergic to muscle relaxants

3. Pregnant females, breastfeeding females

4. History of chronic obstructive pulmonary disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath